Thursday, May 26, 2022

ਵਾਹਿਗੁਰੂ

spot_img





Corbevax gets EUA for children aged 5-12 years

Hyderabad, April 26, 2022 – Vaccine maker Biological E. Ltd on Tuesday announced that its Covid-19 vaccine Corbevax has received a nod from the Drugs Controller General of India (DCGI) for emergency use authorisation for the 5-12-year age group.

The approval comes after the Subject Expert Committee (SEC) recommendation based on the review of interim safety and immunogenicity data of Corbevax for this age bracket. This approval comes a month after Corbevax was given the nod for children between 12 and 15 years, Hyderabad-based BE said.

The company has developed India’s first indigenous sub-unit Covid-19 against the novel coronavirus. It performed a multi-centric, Phase 2/3 clinical trial in 624 children aged between 5 and 18 in two age subsets, i.e., 12 to less than 18 years and 5 to less than 12 years. As a part of the trial, children were administered two doses of 0.5 ml each of the vaccine or placebo in a gap of 28 days.

BE submitted the interim safety data and immunogenicity data to regulatory agencies. For both the age subsets, the trial showed a significant increase in the anti-RBD IgG antibodies and neutralising antibodies (nAb) against ancestral strain and Delta variant. The titers observed post vaccination with Corbevax in the paediatric cohorts were comparable to the adult cohort evaluated in earlier clinical trials and the vaccine showed excellent safety for both age groups.

“This is a great opportunity to get back to some level of normalcy in our continuing fight against the prevalent pandemic situation as Corbevax is the first indigenous Covid-19 vaccine in the country that addresses the vaccination needs of all age groups from 5 years and above,” said Mahima Datla, Managing Director, Biological E.

The company revealed that it has so far manufactured 30 crore doses of Corbevax and has already supplied nearly 10 crore doses to the government. Currently, over 3 crore doses of Corbevax have been administered in children between 12-15 years of age. With an approval for the 5-12 age group, this move will not only reduce the risks children face from the infectious disease, but it will also enable them to concentrate on their education and social development, which were severely impacted by the pandemic.

Getting their kids vaccinated will also help ease parents’ concerns while sending them to school, it added.  (Agency)

Subscribe to YesPunjab Telegram Channel & receive important news updates

- Advertisement -

Yes Punjab - TOP STORIES

Punjab News

Sikh News

Transfers, Postings, Promotions

- Advertisement -spot_img

Stay Connected

20,323FansLike
114,308FollowersFollow

ENTERTAINMENT

National

GLOBAL

OPINION

Making a career based on a hobby is a wise step – by Narvijay Yadav

In my first few years in journalism, my mind was so engrossed in the work that it seemed like fun to me. I was...

Trade focussed Quad – by Asad Mirza

The first in-person meeting of the leaders of the US, Australia, Japan and India, termed Quad, will be held in Tokyo on Tuesday. This...

How much and how often should courts adjudicate matters of religous fervour? – by Adeel Ahmed

New Delhi, May 22, 2022- In the old city of Jerusalem, there lies a 187-foot long ‘Western Wall, built by Herod on the western...

SPORTS

Health & Fitness

Preterm birth: Warning signs that indicate complications during pregnancy

New Delhi, May 23, 2022 - Preterm birth, defined as a baby born before 37 weeks of pregnancy, is a leading cause of infant death and can result in long-term disabilities for those who survive. Each year, approximately 1 million children die as a result of preterm birth complications. According to the World Health Organization, many survivors will live...

Gadgets & Tech